Target Name: MIR4797
NCBI ID: G100616216
Other Name(s): hsa-miR-4797-3p | MicroRNA 4797 | hsa-miR-4797-5p | microRNA 4797 | hsa-mir-4797

MIR4797: A Potential Drug Target and Biomarker

MIR4797 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the superfamily of cytoskeletal proteins, known as the intermediate filament proteins. MIR4797 is characterized by its unique structure, which consists of a long amino acid sequence followed by a short helix and a long terminal filament.

MIR4797 functions as a protein that can interact with various transcription factors, including NF-kappa-B, p53, and SMAD. It has been shown to play a role in the regulation of cellular processes such as cell growth, apoptosis, and inflammation.

One of the most promising aspects of MIR4797 is its potential as a drug target. The MIR4797 protein has been shown to interact with various small molecules, including inhibitors of NF-kappa-B signaling. This suggests that MIR4797 may be an effective target for drugs that are designed to inhibit the activity of this transcription factor.

In addition to its potential as a drug target, MIR4797 has also been shown to be a potential biomarker. The expression of MIR4797 has been shown to be regulated by various factors, including DNA methylation and histone modifications. This suggests that MIR4797 expression may be a useful biomarker for diseases that are characterized by disruptions in these processes, such as cancer.

Another potential application of MIR4797 is its use as a therapeutic agent. The MIR4797 protein has been shown to be expressed in various tissues of the body, including the brain, heart, and kidneys. This suggests that it may be a potential target for therapies that are designed to deliver drugs or other therapeutic agents to these tissues.

In conclusion, MIR4797 is a protein that has the potential to be a drug target and biomarker. Its unique structure and function make it an attractive target for researchers who are working to develop new therapies for a variety of diseases. Further research is needed to fully understand the role of MIR4797 in cellular processes and its potential as a therapeutic agent.

Protein Name: MicroRNA 4797

More Common Targets

MIR4798 | MIR4799 | MIR4800 | MIR4802 | MIR4803 | MIR4804 | MIR483 | MIR484 | MIR485 | MIR486-1 | MIR486-2 | MIR487A | MIR487B | MIR488 | MIR489 | MIR490 | MIR491 | MIR492 | MIR493 | MIR494 | MIR495 | MIR496 | MIR497 | MIR497HG | MIR498 | MIR4999 | MIR499A | MIR499B | MIR5000 | MIR5001 | MIR5002 | MIR5003 | MIR5004 | MIR5006 | MIR5007 | MIR5008 | MIR5009 | MIR500A | MIR500B | MIR501 | MIR5010 | MIR5011 | MIR502 | MIR503 | MIR503HG | MIR504 | MIR5047 | MIR505 | MIR506 | MIR507 | MIR508 | MIR5088 | MIR5089 | MIR509-1 | MIR509-2 | MIR509-3 | MIR5090 | MIR5091 | MIR5092 | MIR5093 | MIR5094 | MIR510 | MIR5100 | MIR511 | MIR511-2 | MIR512-1 | MIR512-2 | MIR513A1 | MIR513A2 | MIR513B | MIR513C | MIR514A1 | MIR514A2 | MIR514A3 | MIR514B | MIR515-1 | MIR515-2 | MIR516A1 | MIR516A2 | MIR516B1 | MIR516B2 | MIR517A | MIR517B | MIR517C | MIR5186 | MIR5187 | MIR5188 | MIR5189 | MIR518A1 | MIR518A2 | MIR518B | MIR518C | MIR518D | MIR518E | MIR518F | MIR5190 | MIR5191 | MIR5192 | MIR5193 | MIR5194